April 12, 2017
A proposed class of Investors in Tokai Pharmaceuticals Inc. on Tuesday hit the drugmaker with a suit in Massachusetts federal court, alleging shortcomings in the proxy statement surrounding a deal in which shareholders of Otic Pharma Ltd. would become Tokai's majority owner.